Dasatinib 70mgTablet
Anti-Cancer

Dasatinib 70mg

Dasatinib

Second-generation dual SRC/ABL kinase inhibitor with 325-fold greater potency than imatinib against unmutated BCR-ABL, effective across most imatinib-resistant BCR-ABL mutations except T315I. Approved for newly diagnosed CML-CP and all phases of imatinib-resistant CML and Ph+ ALL. Cipla and Natco supply affordable generics for oncology export.

Strengths

20mg / 50mg / 70mg / 100mg

Packing

60 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Dasatinib 20mg / 50mg / 70mg / 100mg
Dosage Form
Tablet
Available Strengths
20mg / 50mg / 70mg / 100mg
Packing
60 tablets/bottle
Route of Administration
Oral, with or without food
Dosage
CML-CP: 100mg once daily; CML-AP/BP or Ph+ ALL: 140mg once daily
Indications
Newly diagnosed CML chronic phase, imatinib-resistant CML all phases, Philadelphia chromosome-positive ALL
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Myelosuppression, fluid retention, pleural effusion, diarrhea, headache, fatigue, nausea, rash
Precautions
Pleural effusion monitoring (chest X-ray if dyspnea); myelosuppression management; QTc prolongation risk; pulmonary arterial hypertension reported; avoid antacids within 2 hours

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sorafenib 200mgTablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg
Lenalidomide 25mgCapsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg
Imatinib 400mgTablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Dasatinib 70mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote